NCT00144586View on ClinicalTrials.gov

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MRA(Tocilizumab)

8mg/kg/4 weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY